- Types of Eczema
- Child Eczema
- Eczema Products
- Get Involved
Following on the heels of Dupixent (dupilumab)—the first-ever biologic drug for atopic dermatitis (the most common type of eczema), approved by the U.S. Food and Drug Administration (FDA) on March 28—a second biologic may soon be on the way.
Children as young as three-years-old begin to notice differences about others (Chernyshov, 2016) and react to these differences. Sometimes, they are just curious and no harm is intended. Sometimes bullying follows. Bullying can occur in the form of verbal, physical, social or psychological taunts that are harmful, repetitive and involve an imbalance of power. It […]
From dust mites to pet dander, we walk you through the common triggers for asthma and allergic rhinitis and show you how to manage symptoms. May 23, 2017 By Kathryn Jones If you have atopic dermatitis (AD), you’ve probably heard the terms “atopic march” or “atopic triad.” This is when people with AD also develop […]
New research reveals a type of yeast found in infants’ stomachs may be strong predictor of childhood asthma.
Bust out that yoga mat because researchers are getting closer to understanding the benefits of stress reduction for inflammatory skin diseases.
The U.S. Food and Drug Administration approved Dupixent (dupilumab), the first biologic medication for adults with moderate to severe atopic dermatitis (AD).
Our skin is covered in a web of billions of tiny organisms including bacteria, viruses and fungi. This web is called the skin microbiome and when healthy, helps our bodies function properly inside and out. Researchers have long known that people with atopic dermatitis (AD) have different skin biology than those who do not have […]
Each year, thousands of doctors, scientists, students, industry and patient advocacy groups like National Eczema Association, gather to hear the latest research and standards of medical care in dermatology at the American Academy of Dermatology (AAD) Annual Meeting. Photo Credit Dermatology World Atopic dermatitis is a hot field of study. Here’s some highlights from this […]
To find out more about why and how pain and sleep problems affect people with atopic dermatitis, the National Eczema Association funded three studies in these areas as part of its 2017 Research Grant Program.
Biologic drugs have been making headlines as potentially promising new therapies for treating atopic dermatitis (AD). Several have shown positive results in clinical trials and one, dupilumab, is being reviewed for approval by the Food and Drug Administration (FDA) and is expected to come to market in 2017. Biologic medications are already being used to […]